AI Article Synopsis
- Egypt has a high prevalence of hepatitis C and this study investigated the ophthalmological side effects of PEGylated interferon (PEG IFN) and ribavirin (RBV) therapy.
- Out of 100 patients analyzed, 9% exhibited IFN-induced retinopathy, predominantly appearing at week 12, with asymptomatic cases and a significant proportion being non-responders to treatment.
- Factors like older age, diabetes, hypertension, and non-response to therapy were linked to more severe retinopathy, highlighting the need for regular ophthalmological assessments during treatment.
Article Abstract
Background: Egypt has one of the highest prevalence of hepatitis C virus (HCV) worldwide. Ophthalmological side effects are recognized complications of interferon (IFN) therapy. This study aimed to evaluate IFN-induced ophthalmological manifestations in patients receiving PEGylated interferon (PEG IFN) and ribavirin (RBV) and to assess the effect of IFN duration, response and systemic risk factors on the severity.
Methods: We retrospectively analyzed 100 patients with chronic HCV who were candidates for PEG-IFN and RBV therapy. All patients were subjected to clinical and ophthalmological examination, laboratory investigations, abdominal ultrasound, colored fundus photography and fundus fluorescein angiography, follow up was made at weeks 12, 24, and 48 of treatment.
Results: IFN-induced retinopathy had been found in (9/100; 9%), 5 (5/9; 55.5%) of them had bilateral lesions, (3/9; 33.3%) were treatment responders and (6/9; 66.6%) non responders. The time of retinopathy appearance was mainly at W12. Retinopathy was asymptomatic in most of the affected patients (7/9; 77.77%) and reversible, cotton wool spots was the major associated sign. Patients with older age, DM and or HTN, and non-responders to antiviral therapy were associated with more severe retinopathy.
Conclusions: Retinopathy is not a rare complication of IFN therapy for chronic HCV infection, but fortunately it's asymptomatic and reversible. Ophthalmological assessment at base-line and at follow up during IFN treatment is very important.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876243 | PMC |
| http://dx.doi.org/10.21037/hbsn.2015.12.14 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Estimation of Average Intraocular Lens Power for Cataract Surgeries in Trincomalee District, Sri Lanka: A Single-Centre Retrospective Descriptive Study.
Cureus
November 2024
Ophthalmology, District General Hospital Trincomalee, Trincomalee, LKA.
Introduction The Sri Lankan economic crisis that began in 2019 led to the suspension of cataract services in many districts. Although humanitarian missions were quick to supply materials, there was a lack of scientific evidence to predict the required intraocular lens power for patients with cataracts. This study aimed to assess the average lens power among patients from Trincomalee district, Sri Lanka, based on sex and age groups.
View Article and Find Full Text PDFBilateral Reversible Corneal Edema as a Novel Side-Effect of Levetiracetam - A Case Report.
Int Med Case Rep J
December 2024
Department of Ophthalmology, Mater Dei Hospital, Imsida, MSD, 2090, Malta.
Purpose: We present a case of levetiracetam-induced corneal edema. To the best of our knowledge, this is the first documented case of bilateral reversible corneal edema secondary to levetiracetam use.
Patients And Methods: A 59-year-old woman was referred to the ophthalmology department with a few weeks' history of bilateral blurring of vision.
Pupilmate: A do-it-yourself frugal pupilometer.
Indian J Ophthalmol
December 2024
Department of Retina and Vitreous Services, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India.
The pupillary direct and consensual reflex is an important non-invasive quick assessment of the neurological state of the eye. Currently, there is no cheap and affordable recording tool for screening and documentation of a relative afferent pupillary defect. We describe how to construct a frugal, do-it-yourself handheld scotopic binocular pupillometer device called Pupilmate.
View Article and Find Full Text PDFUncommon but Significant: Onset, Characteristics and Management of Vasculitis and Connective Tissue Diseases Induced by Immunomodulators during Cancer Treatment.
Discov Med
December 2024
Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.
The introduction of immunomodulators as adjuvant therapies in cancer treatment has represented a significant advancement in oncology, improving therapeutic response and patient survival. Emerging targets and molecules could provide new therapeutic opportunities for cancer patients. However, these agents can induce immunological side effects, including vasculitis and connective tissue diseases, which, while uncommon, present significant clinical challenges.
View Article and Find Full Text PDFHSP90 stabilizes visual cycle retinol dehydrogenase 5 in the endoplasmic reticulum by inhibiting its degradation during autophagy.
J Biol Chem
December 2024
The Laboratory of Ophthalmology and Vision Science, Department of Ophthalmology, The Joint National Laboratory of Antibody Drug Engineering, Henan Province Engineering Research Center of Fundus Disease and Ocular Trauma Prevention and Treatment, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China; Henan International Joint Research Laboratory for Ocular Immunology and Retinal Injury Repair, Zhengzhou, China; Kaifeng Key Lab for Cataracts and Myopia, Kaifeng Central Hospital, Kaifeng, China; Eye Institute, Henan Academy of Innovations in Medical Science, Zhengzhou, China. Electronic address:
Genetic mutations in retinol dehydrogenase 5 (RDH5), a rate-limiting enzyme of the visual cycle, is associated with nyctalopia, AMD and stationary congenital fundus albipunctatus (FA). A majority of these mutations impair RDH5 protein expression and intracellular localization. However, the regulatory mechanisms underlying RDH5 metabolism remain unclear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!